Newsroom

Sorted by: Latest

-

Futurum Group Enters Definitive Agreement to Acquire Aptiviti Inc., Parent of Enterprise Technology Research (ETR), Bringing Wall Street’s Premier Predictive Data into its Futurum Intelligence Platform™

AUSTIN, Texas--(BUSINESS WIRE)--The acquisition integrates Aptiviti’s ETR institutional-grade spending data into Futurum Intelligence Platform™ enhancing the range of intelligence...
-

Virchow Medical Strengthens Scientific Advisory Board with New Appointments

SAN DIEGO--(BUSINESS WIRE)--Virchow strengthens Scientific Advisory Board; appoints Mayo Clinic Laboratories CEO Dr. William Morice & Clinical Lab 2.0 Founder Khosrow Shotorban...
-

Eric Mosley, Founder and CEO of Workhuman, honoured with Visionary Leaders Award at Dublin Tech Summit

DUBLIN--(BUSINESS WIRE)--Eric Mosley, Founder and CEO of Workhuman, has been awarded the Visionary Leaders Award at this year’s Dublin Tech Summit, recognising his leadership in shaping the future of work through technology and human connection. Mosley was presented with the award at Dublin Tech Summit’s annual Leaders Dinner, where he was selected as one of two 2026 award recipients, with the evening spotlighting global tech leaders whose work continues to shape the future of business and tech...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 26.05.2026 GINC LN IE00BD842Y21 899,606.00 USD 57,963,650.20 64.432  ...
-

ClearNote Health Secures $52 Million in Series D Financing and Strengthens Leadership Team to Accelerate Growth in Early Cancer Detection

SAN DIEGO--(BUSINESS WIRE)--ClearNote Health announced the close of $52 million in Series D financing and appointment of Kevin Keegan as president and chief operating officer....
-

Junevity to Present Breakthrough Research on siRNA Therapeutics at American Aging Association’s 2026 Annual Meeting

SAN FRANCISCO--(BUSINESS WIRE)--Junevity to Present Breakthrough Research on siRNA Therapeutics at American Aging Association’s 2026 Annual Meeting...
-

ICE's Total Futures and Options at Record Open Interest as Global Natural Gas and Power Markets Reach Record Levels of Liquidity

LONDON & NEW YORK & AMSTERDAM--(BUSINESS WIRE)--Intercontinental Exchange, Inc. (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets, and home to the largest and most liquid markets to trade energy derivatives, today announced record liquidity across its global natural gas and power markets, including record open interest (OI) across North American natural gas, as ICE reached record total OI across its futures and options mark...
-

Arima Genomics Announces Presentation of New Data at ASCO 2026 Supporting Clinical Utility of Hi-C Sequencing in Non-Small Cell Lung Cancer

CARLSBAD, Calif.--(BUSINESS WIRE)--Arima Genomics, Inc., a cancer diagnostics company bringing DNA sequence and structure together to advance cancer therapy selection, today announced that it will present new data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29-June 2 in Chicago. The findings in the poster presentation demonstrate the value of Arima’s Hi-C sequencing-based approach to fusion and rearrangement detection, available clinically through t...
-

MindWalk Holdings Deploys Pandemic Response Platform via HYFT® Technology as Ebola and Hantavirus Outbreaks Expose the Limits of Strain-Specific Coverage

AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. (NASDAQ: HYFT), a bio-native AI therapeutic research and technology company, today announced the launch of its Pandemic Response Platform, a deployment configuration of the Company's proprietary HYFT® biological pattern system and LensAI™ platform purpose-built for outbreak preparedness, rapid countermeasure design, and pan-strain antigen and antibody generation against RNA viruses. The Platform draws on the same biological intelligence in...
-

Silence Therapeutics to Participate in Jefferies Global Healthcare Conference

LONDON--(BUSINESS WIRE)--Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage biotechnology company developing novel siRNA (short interfering RNA) therapies, today announced that management will participate in an analyst-led fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 3, 2026 at 4:55 p.m. ET. A live webcast can be accessed in the Investors section of the Silence website at www.silence-therapeutics.com. An archived replay of the webcast will be avail...